Remove Government Remove Patients Remove Pharma Remove Prescription
article thumbnail

The hypocrisy of big pharma

World of DTC Marketing

The suggestion by Pfizer’s CEO that drug pricing negotiations with the government would slow innovation is PR doubletalk. To me, this says that the approval of the drug WAS about money, not patients. The post The hypocrisy of big pharma. trillion social spending package. Then there is the tale of Biogen.

Pharma 214
article thumbnail

The debate on DTC marketing is going to heat up again

World of DTC Marketing

SUMMARY: DTC marketing is not the reason why prescription drugs cost so much. Here are some myths around DTC marketing: 1ne: DTC ads result in patients asking for prescriptions they don’t need. 2wo: DTC marketing is one of the reasons prescription drugs cost so much. DTC ads raise awareness around health conditions.

Marketing 285
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The drug industry can’t fight change

World of DTC Marketing

Today’s pharma CEOs should prepare their organizations for the future, not wasting money with lobbying costs. Industry lobbyists claim that any government attempt to intervene in pharmaceutical companies’ price-setting would stifle innovation and prolong the fight against Covid-19. Bernie Sanders (I-Vt.),

article thumbnail

Improving COVID Care Delays: How Pharma Companies Can Help Patients

PM360

And even though the system seems to be returning to some semblance of normalcy, it’s going to take a village to help patients and the industry get back to full health. Patients appear to have fundamentally changed how they use healthcare services, from embracing telehealth and digital tools to foregoing care. Stress Cracks.

article thumbnail

Value-based healthcare can help reduce costs

World of DTC Marketing

Value-based healthcare is a healthcare delivery model in which providers, including hospitals and physicians, are paid based on patient health outcomes. Value-based models encourage a team-oriented approach to patient care. Prescription drugs costs are just a small part of healthcare costs (11%). health care system.

article thumbnail

What do future healthcare CEOs look like?

World of DTC Marketing

QUICK READ: The compensation for pharma CEOs is starting to be reported and it’s off the charts. Pharma, PBM, and health insurance CEOs earn hundreds of millions of dollars to do one thing; make their companies a lot of money. Government funding contributed to research associated with all 210 new drugs approved by the U.S.

article thumbnail

Specialty pharma’s next big opportunity: it’s time for patient access to adopt an open protocol

pharmaphorum

a power Visa and ultimately the government could not deny. Along their journey, specialty pharma patients interact with a series of siloed institutions: clinics, specialty pharmacies, copay program vendors, patient assistance programs, nurses, etc. to make the patient experience as seamless as possible.